The relationship among vedolizumab drug concentrations, biomarkers of inflammation, and clinical outcomes in a Canadian real-world study.
Cynthia H-T SeowJohn K MarshallErin StewartChristopher PettengellRyan WardWaqqas AfifPublished in: Journal of the Canadian Association of Gastroenterology (2024)
NCT04567628.